REGN Shareholders Have Opportunity to Lead Regeneron Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and certain officers for alleged violations of federal securities laws. The lawsuit covers those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
January 26, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged violations of federal securities laws, potentially impacting its stock price.
The lawsuit against Regeneron for alleged securities law violations could lead to negative investor sentiment and potential financial liabilities, likely impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100